AAPL352.36+20.46 (+6.16%) ▲|ABBV291.96+5.96 (+2.08%) ▲|ABT115.64+6.24 (+5.70%) ▲|ACN266.76+12.20 (+4.79%) ▲|ADBE249.53+3.39 (+1.38%) ▲|AMAT365.00-16.92 (-4.43%) ▼|AMD484.19+0.29 (+0.06%) ▲|AMGN480.01+18.75 (+4.07%) ▲|AMT194.30+7.01 (+3.74%) ▲|AMZN268.12+17.43 (+6.95%) ▲|AVGO325.99-6.14 (-1.85%) ▼|AXP331.86+6.36 (+1.95%) ▲|BA176.72+3.41 (+1.96%) ▲|BAC51.35+1.69 (+3.40%) ▲|BKNG171.18+15.51 (+9.96%) ▲|BLK1,220.85+59.53 (+5.13%) ▲|BMY63.55+1.84 (+2.98%) ▲|BNY151.85+2.54 (+1.70%) ▲|BRK-B578.83+21.76 (+3.91%) ▲|C124.53+1.82 (+1.48%) ▲|CAT589.23-34.71 (-5.56%) ▼|CL98.68+3.06 (+3.20%) ▲|CMCSA24.55+0.88 (+3.70%) ▲|COF207.14-1.57 (-0.75%) ▼|COP135.86-8.54 (-5.91%) ▼|COST1,049.28+30.02 (+2.95%) ▲|CRM227.99+5.79 (+2.61%) ▲|CSCO103.09+0.12 (+0.12%) ▲|CVS80.93-10.48 (-11.46%) ▼|CVX216.80-8.48 (-3.76%) ▼|DE676.75+10.92 (+1.64%) ▲|DHR235.62+5.51 (+2.39%) ▲|DIS118.83+4.65 (+4.07%) ▲|DUK129.69+3.18 (+2.51%) ▲|EMR170.56+4.17 (+2.50%) ▲|FDX327.54+9.52 (+2.99%) ▲|GD365.18-9.32 (-2.49%) ▼|GE328.00+7.33 (+2.29%) ▲|GEV831.04-87.16 (-9.49%) ▼|GILD174.85+7.38 (+4.41%) ▲|GM92.19+3.85 (+4.36%) ▲|GOOG289.45+11.18 (+4.02%) ▲|GOOGL291.13+11.10 (+3.96%) ▲|GS927.52+31.43 (+3.51%) ▲|HD354.31+20.65 (+6.19%) ▲|HON227.47+3.42 (+1.53%) ▲|IBM255.06+5.02 (+2.01%) ▲|INTC57.95-2.60 (-4.29%) ▼|INTU359.05+14.33 (+4.16%) ▲|ISRG484.44+43.69 (+9.91%) ▲|JNJ276.55+10.38 (+3.90%) ▲|JPM350.66+12.68 (+3.75%) ▲|KO96.22+1.42 (+1.49%) ▲|LIN524.66+13.11 (+2.56%) ▲|LLY1,418.13+8.75 (+0.62%) ▲|LMT595.51-43.50 (-6.81%) ▼|LOW228.90+15.52 (+7.27%) ▲|LRCX219.64-11.09 (-4.80%) ▼|MA671.34+24.16 (+3.73%) ▲|MCD279.21+16.17 (+6.15%) ▲|MDLZ67.39+2.27 (+3.49%) ▲|MDT105.33+6.45 (+6.52%) ▲|META630.50+9.47 (+1.52%) ▲|MMM194.15+17.10 (+9.66%) ▲|MO77.80+0.86 (+1.12%) ▲|MRK149.22+4.55 (+3.15%) ▲|MS192.90+6.81 (+3.66%) ▲|MSFT558.97+37.98 (+7.29%) ▲|MU796.53-58.57 (-6.85%) ▼|NEE88.43+4.10 (+4.86%) ▲|NFLX66.49+3.07 (+4.83%) ▲|NKE40.18+1.70 (+4.42%) ▲|NOW110.43+1.27 (+1.16%) ▲|NVDA202.27-4.42 (-2.14%) ▼|ORCL124.23-1.96 (-1.55%) ▼|PEP142.67+5.40 (+3.93%) ▲|PFE30.73+0.73 (+2.42%) ▲|PG167.27+5.21 (+3.21%) ▲|PLTR172.47-2.93 (-1.67%) ▼|PM210.21+2.18 (+1.05%) ▲|QCOM165.06+0.63 (+0.38%) ▲|RTX197.28-6.54 (-3.21%) ▼|SBUX108.70+3.93 (+3.75%) ▲|SCHW93.59+4.31 (+4.82%) ▲|SO93.31-0.44 (-0.47%) ▼|SPG227.99+5.91 (+2.66%) ▲|T21.71+0.32 (+1.51%) ▲|TMO706.49+8.15 (+1.17%) ▲|TMUS158.27+3.86 (+2.50%) ▲|TSLA386.61-11.90 (-2.98%) ▼|TXN310.48-2.01 (-0.64%) ▼|UBER70.43+3.83 (+5.75%) ▲|UNH414.63+10.19 (+2.52%) ▲|UNP308.06+4.63 (+1.53%) ▲|UPS114.27+5.10 (+4.67%) ▲|USB60.84+0.95 (+1.58%) ▲|V434.64+14.22 (+3.38%) ▲|VZ46.11+0.87 (+1.92%) ▲|WFC87.42+1.89 (+2.20%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM169.40-8.06 (-4.54%) ▼|AAPL352.36+20.46 (+6.16%) ▲|ABBV291.96+5.96 (+2.08%) ▲|ABT115.64+6.24 (+5.70%) ▲|ACN266.76+12.20 (+4.79%) ▲|ADBE249.53+3.39 (+1.38%) ▲|AMAT365.00-16.92 (-4.43%) ▼|AMD484.19+0.29 (+0.06%) ▲|AMGN480.01+18.75 (+4.07%) ▲|AMT194.30+7.01 (+3.74%) ▲|AMZN268.12+17.43 (+6.95%) ▲|AVGO325.99-6.14 (-1.85%) ▼|AXP331.86+6.36 (+1.95%) ▲|BA176.72+3.41 (+1.96%) ▲|BAC51.35+1.69 (+3.40%) ▲|BKNG171.18+15.51 (+9.96%) ▲|BLK1,220.85+59.53 (+5.13%) ▲|BMY63.55+1.84 (+2.98%) ▲|BNY151.85+2.54 (+1.70%) ▲|BRK-B578.83+21.76 (+3.91%) ▲|C124.53+1.82 (+1.48%) ▲|CAT589.23-34.71 (-5.56%) ▼|CL98.68+3.06 (+3.20%) ▲|CMCSA24.55+0.88 (+3.70%) ▲|COF207.14-1.57 (-0.75%) ▼|COP135.86-8.54 (-5.91%) ▼|COST1,049.28+30.02 (+2.95%) ▲|CRM227.99+5.79 (+2.61%) ▲|CSCO103.09+0.12 (+0.12%) ▲|CVS80.93-10.48 (-11.46%) ▼|CVX216.80-8.48 (-3.76%) ▼|DE676.75+10.92 (+1.64%) ▲|DHR235.62+5.51 (+2.39%) ▲|DIS118.83+4.65 (+4.07%) ▲|DUK129.69+3.18 (+2.51%) ▲|EMR170.56+4.17 (+2.50%) ▲|FDX327.54+9.52 (+2.99%) ▲|GD365.18-9.32 (-2.49%) ▼|GE328.00+7.33 (+2.29%) ▲|GEV831.04-87.16 (-9.49%) ▼|GILD174.85+7.38 (+4.41%) ▲|GM92.19+3.85 (+4.36%) ▲|GOOG289.45+11.18 (+4.02%) ▲|GOOGL291.13+11.10 (+3.96%) ▲|GS927.52+31.43 (+3.51%) ▲|HD354.31+20.65 (+6.19%) ▲|HON227.47+3.42 (+1.53%) ▲|IBM255.06+5.02 (+2.01%) ▲|INTC57.95-2.60 (-4.29%) ▼|INTU359.05+14.33 (+4.16%) ▲|ISRG484.44+43.69 (+9.91%) ▲|JNJ276.55+10.38 (+3.90%) ▲|JPM350.66+12.68 (+3.75%) ▲|KO96.22+1.42 (+1.49%) ▲|LIN524.66+13.11 (+2.56%) ▲|LLY1,418.13+8.75 (+0.62%) ▲|LMT595.51-43.50 (-6.81%) ▼|LOW228.90+15.52 (+7.27%) ▲|LRCX219.64-11.09 (-4.80%) ▼|MA671.34+24.16 (+3.73%) ▲|MCD279.21+16.17 (+6.15%) ▲|MDLZ67.39+2.27 (+3.49%) ▲|MDT105.33+6.45 (+6.52%) ▲|META630.50+9.47 (+1.52%) ▲|MMM194.15+17.10 (+9.66%) ▲|MO77.80+0.86 (+1.12%) ▲|MRK149.22+4.55 (+3.15%) ▲|MS192.90+6.81 (+3.66%) ▲|MSFT558.97+37.98 (+7.29%) ▲|MU796.53-58.57 (-6.85%) ▼|NEE88.43+4.10 (+4.86%) ▲|NFLX66.49+3.07 (+4.83%) ▲|NKE40.18+1.70 (+4.42%) ▲|NOW110.43+1.27 (+1.16%) ▲|NVDA202.27-4.42 (-2.14%) ▼|ORCL124.23-1.96 (-1.55%) ▼|PEP142.67+5.40 (+3.93%) ▲|PFE30.73+0.73 (+2.42%) ▲|PG167.27+5.21 (+3.21%) ▲|PLTR172.47-2.93 (-1.67%) ▼|PM210.21+2.18 (+1.05%) ▲|QCOM165.06+0.63 (+0.38%) ▲|RTX197.28-6.54 (-3.21%) ▼|SBUX108.70+3.93 (+3.75%) ▲|SCHW93.59+4.31 (+4.82%) ▲|SO93.31-0.44 (-0.47%) ▼|SPG227.99+5.91 (+2.66%) ▲|T21.71+0.32 (+1.51%) ▲|TMO706.49+8.15 (+1.17%) ▲|TMUS158.27+3.86 (+2.50%) ▲|TSLA386.61-11.90 (-2.98%) ▼|TXN310.48-2.01 (-0.64%) ▼|UBER70.43+3.83 (+5.75%) ▲|UNH414.63+10.19 (+2.52%) ▲|UNP308.06+4.63 (+1.53%) ▲|UPS114.27+5.10 (+4.67%) ▲|USB60.84+0.95 (+1.58%) ▲|V434.64+14.22 (+3.38%) ▲|VZ46.11+0.87 (+1.92%) ▲|WFC87.42+1.89 (+2.20%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM169.40-8.06 (-4.54%) ▼|
22.1 C
New York
Wednesday, November 4, 2026

Tag: center

newsFORsourcecompanycontentinformationreleases1market

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

Dialogue on China-ASEAN Cultural Heritage Successfully Concludes in Tianshui

TIANSHUI, China, June 21, 2025 /PRNewswire/ -- To encourage exchange and cooperation in cultural heritage preservation, promote mutual learning among civilizations, and advance the...

ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

Weitere Gründungsmitglieder sind die European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis und RayzeBio, ein Unternehmen von Bristol Myers Squibb.

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

Further founding members include the European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis, and RayzeBio, a Bristol Myers Squibb company.

TEAMSTERS NURSES AT COREWELL TO RALLY AGAINST EMPLOYERS’ ATTACKS

Nurses to Rally Outside Detroit Ahead of Contract Negotiations DETROIT, June 21, 2025 /PRNewswire/ -- Nurses at Corewell Health East, represented by Teamsters Local 2024, will...

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science 
From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science

Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes...

New Research on Abbott’s Healthy Food Rx Program Shows ‘Food is Medicine’ Approach Helps People Living With Diabetes Eat Better and Feel Healthier

Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and...

Studies show promising results for individuals with type 2 diabetes and young children with type 1 diabetes on MiniMed™ 780G system

Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology. GALWAY, Ireland and...

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

Both subcutaneous and oral formulations will advance straight to phase 3 development based on completed clinical studies and feedback received from regulatory authorities1,2PLAINSBORO, N.J.,...

Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide

MPC-inhibitor 0602K shows significant preservation of lean mass & increased muscle function combined with tirzepatide in pre-clinical DIO models0602K shows profound beneficial transformation of...

The Inner Circle acknowledges, Dr. Ashley Poklar a Pinnacle Professional Member

CHAGRIN, Ohio, June 20, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Ashley Poklar is acknowledged as a Pinnacle Professional Member Inner Circle...

The Ensign Group, Inc. Announces Retirement of Its Executive Chairman

SAN JUAN CAPISTRANO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG or “Ensign”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that Christopher Christensen, Executive Chairman and member of the Ensign Board of Directors, has provided notice to the board of his intent to retire from both his roles effective September 1, 2025.

PARKE BANCORP, INC. ANNOUNCES CASH DIVIDEND

WASHINGTON TOWNSHIP, N.J., June 20, 2025 /PRNewswire/ -- Parke Bancorp, Inc. (the "Company") (NASDAQ: PKBK) today announced the declaration of a $0.18 per share...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCenter

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers